Pectoral muscle hematoma as a complication of Covid-19 treatment: A Case Report
In COVID-19 disease, the activation of the coagulation system is increasing. Here we presented a case of COVID-19 who developed a hematoma in the pectoral muscle possibly associated with anticoagulation therapy.
Main Authors: | Yıldız Okuturlar, Damla Gürleyik, Nur Ramoğlu, Yasemin Gündoğdu, İftihar Köksal |
---|---|
Format: | Article |
Language: | English |
Published: |
Nizameddin KOCA
2021-03-01
|
Series: | Turkish Journal of Internal Medicine |
Subjects: | |
Online Access: | https://dergipark.org.tr/tr/download/article-file/1565183 |
Similar Items
-
Does Antithrombotic Therapy Affect Outcomes in Major Trauma Patients? A Retrospective Cohort Study from a Tertiary Trauma Centre
by: Stefano Sartini, et al.
Published: (2022-09-01) -
Late presentation of factor XIII deficiency with recurrent muscle hematomas
by: Sudesh Kumar, et al.
Published: (2023-01-01) -
Non-traumatic epidural posterior fossa hematomas in child with Sensenbrenner syndrome: a case report and literature review
by: Mariana Mazzuia Guimarães, et al.
Published: (2021-05-01) -
Femoral nerve palsy as a complication due to COVID-19 coagulopathy and iliopsoas muscle hematoma – case report
by: Sławomir Tutak, et al.
Published: (2023-12-01) -
Preventing Thrombohemorrhagic Complications of Heparinized COVID-19 Patients Using Adjunctive Thromboelastography: A Retrospective Study
by: Connor M. Bunch, et al.
Published: (2021-07-01)